SCOR: The timeline of the 2022 arbitration relating to retrocession treaties remains unchanged

Will the unchanged timeline affect any upcoming regulatory filings or disclosures for SCOR? Are there any potential downstream effects on SCOR's stock volatility or investor sentiment due to this legal update? How does this development compare to similar arbitration or litigation timelines faced by other major reinsurers? What potential financial impact could the unchanged arbitration timeline have on SCOR's earnings and cash flow? How might the delay or continuation of the arbitration affect SCOR's credit ratings and borrowing costs? What are the possible implications for SCOR's reinsurance contracts and existing retrocession treaty obligations? Could the unchanged timeline influence market perception of SCOR's legal risk management and governance? Might the arbitration outcome affect SCOR's competitive positioning in the global reinsurance market? What is the likelihood that the arbitration could result in material liabilities or settlements for SCOR? How could this news impact the pricing of SCOR's bonds or other debt instruments?